Table 1.

Clinico-pathological parameters for the patient cohort

Factor	Total		GATA6				p value
			Negative		Positive
Sex
Female	59	11.9%	53	89.8%	6	10.2%
Male	437	88.1%	394	90.2%	43	9.8%	0.937
Agegroup
< 65 yrs	245	52,5%	216	88.2%	29	11.8%
> 65 yrs	222	47.5%	202	91.0%	20	9.0%	0.319
Tumor stage
pT1/2	125	25.4%	112	89.6%	13	10.4%
pT3/4	368	74.6%	332	90.2%	36	9.8%	0.842
Lymph node metastasis
pN0	198	40.1%	178	89.9%	20	4.0%
pN +	296	59.9%	267	90.2%	29	9.8%	0.912
Grading
G1	5	1.4%	5	1.4%	0	0%
G2	197	55.5%	178	90.4%	19	9.6%
G3	151	42.5%	137	90.7%	14	9.3%
G4	2	0.6%	2	0.6%	0	0%	0.746
UICC
I	108	22.0%	97	89.8%	11	10.2%
II	106	21.5%	96	90.6%	10	9.4%
III	208	42.3%	184	88.5%	24	11.5%
IV	70	14.2%	66	94.3%	4	5.7%	0.567
Neoadjuvant therapy
No	219	44.2%	204	93.2%	15	6.8%
Yes	277	55.8%	243	87.7%	34	12.3%	0.044